REVEL is better at predicting pathogenicity of loss-of-function than gain-of-function variants https://www.medrxiv.org/content/10.1101/2023.06.06.23290963
REVEL is better at predicting pathogenicity of loss-of-function than gain-of-function variants https://www.medrxiv.org/content/10.1101/2023.06.06.23290963